| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |